Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

Protocol for a population-based ankylosing spondylitis (PAS) cohort in Wales.

Atkinson MD, Brophy S, Siebert S, Gravenor MB, Phillips C, Ford DV, Jones KH, Lyons RA.

BMC Musculoskelet Disord. 2010 Sep 1;11:197. doi: 10.1186/1471-2474-11-197.

2.

The Cost of Ankylosing Spondylitis in the UK Using Linked Routine and Patient-Reported Survey Data.

Cooksey R, Husain MJ, Brophy S, Davies H, Rahman MA, Atkinson MD, Phillips CJ, Siebert S.

PLoS One. 2015 Jul 17;10(7):e0126105. doi: 10.1371/journal.pone.0126105. eCollection 2015.

3.

HERALD (health economics using routine anonymised linked data).

Husain MJ, Brophy S, Macey S, Pinder LM, Atkinson MD, Cooksey R, Phillips CJ, Siebert S.

BMC Med Inform Decis Mak. 2012 Mar 29;12:24. doi: 10.1186/1472-6947-12-24.

4.

Severe flare as a predictor of poor outcome in ankylosing spondylitis: a cohort study using questionnaire and routine data linkage.

Cooksey R, Brophy S, Dennis M, Davies H, Atkinson M, Irvine E, Siebert S.

Rheumatology (Oxford). 2015 Sep;54(9):1563-72. doi: 10.1093/rheumatology/kev015. Epub 2015 Mar 22.

PMID:
25802399
5.

Costs and work limitation of patients with ankylosing spondylitis in China.

Tu L, Rai JC, Cao S, Lin Z, Hu Z, Gu J.

Clin Exp Rheumatol. 2014 Sep-Oct;32(5):661-6. Epub 2014 Sep 19.

PMID:
25234798
6.

Resource utilisation and cost of ankylosing spondylitis in Brazil.

Torres TM, Ferraz MB, Ciconelli RM.

Clin Exp Rheumatol. 2010 Jul-Aug;28(4):490-7. Epub 2010 Aug 30.

PMID:
20810034
7.
8.

Ankylosing spondylitis: an Australian experience.

Reed MD, Dharmage S, Boers A, Martin BJ, Buchanan RR, Schachna L.

Intern Med J. 2008 May;38(5):321-7. Epub 2007 Oct 3.

PMID:
17916173
9.

Tumour necrosis factor-╬▒ inhibitors for ankylosing spondylitis and non-radiographic axial spondyloarthritis: a systematic review and economic evaluation.

Corbett M, Soares M, Jhuti G, Rice S, Spackman E, Sideris E, Moe-Byrne T, Fox D, Marzo-Ortega H, Kay L, Woolacott N, Palmer S.

Health Technol Assess. 2016 Feb;20(9):1-334, v-vi. doi: 10.3310/hta20090. Review.

10.

Costs and quality of life of patients with ankylosing spondylitis in Canada.

Kobelt G, Andlin-Sobocki P, Maksymowych WP.

J Rheumatol. 2006 Feb;33(2):289-95.

PMID:
16465660
11.

Clinimetric properties of the ASAS health index in a cohort of Italian patients with axial spondyloarthritis.

Di Carlo M, Lato V, Carotti M, Salaffi F.

Health Qual Life Outcomes. 2016 May 17;14:78. doi: 10.1186/s12955-016-0463-1.

12.

A national population-based e-cohort of people with psychosis (PsyCymru) linking prospectively ascertained phenotypically rich and genetic data to routinely collected records: overview, recruitment and linkage.

Lloyd K, McGregor J, John A, Craddock N, Walters JT, Linden D, Jones I, Bentall R, Lyons RA, Ford DV, Owen MJ.

Schizophr Res. 2015 Aug;166(1-3):131-6. doi: 10.1016/j.schres.2015.05.036. Epub 2015 Jun 29.

PMID:
26139629
13.

[RAISE study observational and cross sectional study to evaluate the actual reality of the socio-economic impact of ankylosing spondylitis].

Miranda L, Negreiro F, Queiroz MJ, Silva C.

Acta Reumatol Port. 2008 Apr-Jun;33(2):189-97. Portuguese.

14.

Large differences in cost of illness and wellbeing between patients with fibromyalgia, chronic low back pain, or ankylosing spondylitis.

Boonen A, van den Heuvel R, van Tubergen A, Goossens M, Severens JL, van der Heijde D, van der Linden S.

Ann Rheum Dis. 2005 Mar;64(3):396-402. Epub 2004 Jul 22.

15.

The burden of ankylosing spondylitis in Spain.

Kobelt G, Sobocki P, Mulero J, Gratacos J, Pocovi A, Collantes-Estevez E.

Value Health. 2008 May-Jun;11(3):408-15. doi: 10.1111/j.1524-4733.2007.00252.x.

16.

Smoking Cessation Intervention for severe Mental Ill Health Trial (SCIMITAR): a pilot randomised control trial of the clinical effectiveness and cost-effectiveness of a bespoke smoking cessation service.

Peckham E, Man MS, Mitchell N, Li J, Becque T, Knowles S, Bradshaw T, Planner C, Parrott S, Michie S, Shepherd C, Gilbody S.

Health Technol Assess. 2015 Mar;19(25):1-148, v-vi. doi: 10.3310/hta19250.

17.

Ankylosing spondylitis: what is the cost to society, and can it be reduced?

Boonen A, Severens JL.

Best Pract Res Clin Rheumatol. 2002 Sep;16(4):691-705. Review.

PMID:
12406435
18.
19.

Healthcare costs and productivity losses directly attributable to ankylosing spondylitis.

Rafia R, Ara R, Packham J, Haywood KL, Healey E.

Clin Exp Rheumatol. 2012 Mar-Apr;30(2):246-53. Epub 2012 Apr 13.

PMID:
22409861
20.

Health-related quality of life in patients with ankylosing spondylitis: a comprehensive review.

Kotsis K, Voulgari PV, Drosos AA, Carvalho AF, Hyphantis T.

Expert Rev Pharmacoecon Outcomes Res. 2014 Dec;14(6):857-72. doi: 10.1586/14737167.2014.957679. Epub 2014 Sep 5. Review.

PMID:
25193010

Supplemental Content

Support Center